bf/NASDAQ:ARWR_icon.jpeg

NASDAQ:ARWR

Arrowhead Pharmaceuticals, Inc.

  • Stock

USD

Last Close

39.60

06/11 22:30

Market Cap

3.33B

Beta: 1.01

Volume Today

1.19M

Avg: 1.11M

PE Ratio

−16.68

PFCF: −12.05

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
Sep '24
revenue
382K
-
158.33K
58.55%
31.41M
19,736.49%
16.14M
48.60%
168.80M
945.67%
87.99M
47.87%
138.29M
57.16%
243.23M
75.89%
240.74M
1.03%
3.55M
98.52%
cost of revenue
gross profit
382K
-
158.33K
58.55%
31.41M
19,736.49%
16.14M
48.60%
168.80M
945.67%
87.99M
47.87%
138.29M
57.16%
243.23M
75.89%
240.74M
1.03%
3.55M
98.52%
selling and marketing expenses
general and administrative expenses
34.72M
-
41.00M
18.09%
32.02M
21.89%
19.11M
40.32%
26.56M
38.96%
52.28M
96.85%
80.98M
54.91%
124.43M
53.65%
92.55M
25.62%
96.82M
4.61%
selling general and administrative expenses
34.72M
-
41.00M
18.09%
32.02M
21.89%
19.11M
40.32%
26.56M
38.96%
52.28M
96.85%
80.98M
54.91%
124.43M
53.65%
92.55M
25.62%
96.82M
4.61%
research and development expenses
57.41M
-
41.45M
27.79%
31.69M
23.55%
52.97M
67.14%
81.05M
53.01%
128.87M
59.01%
206.34M
60.11%
297.31M
44.08%
353.19M
18.80%
505.87M
43.23%
other expenses
417.87K
-
57.35K
86.28%
1.31M
2,188.54%
7.49K
99.43%
-582.52K
-
2.07M
455.35%
5.80M
180.10%
1.54M
73.47%
cost and expenses
96.36M
-
79.85M
17.13%
68.40M
14.34%
72.08M
5.37%
107.60M
49.29%
181.15M
68.35%
287.32M
58.61%
421.74M
46.78%
445.74M
5.69%
604.63M
35.65%
operating expenses
96.36M
-
79.85M
17.13%
68.40M
14.34%
72.08M
5.37%
107.60M
49.29%
181.15M
68.35%
287.32M
58.61%
421.74M
46.78%
445.74M
5.69%
604.63M
35.65%
interest expense
729.16M
-
265.79M
63.55%
415.13M
56.18%
1.05B
152.58%
6.96B
563.58%
9.19B
32.09%
6.12M
99.93%
5.03M
17.76%
18.33M
264.12%
32.35M
76.54%
ebitda
-96.53M
-
-74.08M
23.25%
-33.20M
55.19%
-51.67M
55.65%
65.63M
227.02%
-87.22M
232.89%
-140.77M
61.40%
-178.51M
26.81%
-188.16M
5.41%
-561.51M
198.42%
operating income
-95.97M
-
-81.74M
14.83%
-37.00M
54.74%
-55.94M
51.20%
61.19M
209.39%
-93.16M
252.24%
-149.04M
59.98%
-178.51M
19.77%
-205.00M
14.84%
-601.08M
193.21%
depreciation and amortization
2.34M
-
3.26M
39.54%
4.69M
43.88%
4.70M
0.19%
4.44M
5.54%
5.94M
33.86%
8.27M
39.12%
10.42M
26.06%
12.49M
19.88%
18.59M
48.84%
total other income expenses net
3.31M
-
-2.29M
169.40%
2.20M
196.01%
439.63K
80.04%
6.96M
1,482.63%
8.61M
23.72%
8.19M
4.86%
5.80M
29.21%
1.54M
73.47%
-11.38M
839.92%
income before tax
-91.94M
-
-81.72M
11.11%
-34.38M
57.93%
-54.45M
58.38%
68.15M
225.16%
-84.55M
224.07%
-140.85M
66.58%
-172.71M
22.62%
-206.49M
19.56%
-612.46M
196.60%
income tax expense
2.40K
-
2.40K
0%
2.40K
0%
2.40K
0%
173.55K
7,131.38%
2.40K
98.62%
2K
16.67%
3.79M
189,150%
2.78M
26.45%
-2.77M
199.39%
net income
-91.94M
-
-81.72M
11.11%
-34.38M
57.93%
-54.45M
58.38%
67.97M
224.84%
-84.55M
224.39%
-140.85M
66.58%
-176.49M
25.31%
-205.28M
16.31%
-599.49M
192.04%
weighted average shs out
57.36M
-
61.05M
6.44%
73.90M
21.04%
83.64M
13.18%
93.86M
12.22%
100.72M
7.31%
103.75M
3.00%
105.43M
1.62%
106.75M
1.26%
119.78M
12.21%
weighted average shs out dil
57.36M
-
61.05M
6.44%
73.90M
21.04%
83.64M
13.18%
98.61M
17.90%
100.72M
2.14%
103.75M
3.00%
105.43M
1.62%
106.75M
1.26%
119.78M
12.21%
eps
-1.60
-
-1.34
16.25%
-0.47
64.93%
-0.65
38.30%
0.72
210.77%
-0.84
216.67%
-1.36
61.90%
-1.67
22.79%
-1.92
14.97%
-5
160.42%
epsdiluted
-1.60
-
-1.34
16.25%
-0.47
64.93%
-0.65
38.30%
0.69
206.15%
-0.84
221.74%
-1.36
61.90%
-1.67
22.79%
-1.92
14.97%
-5
160.42%

All numbers in USD (except ratios and percentages)